Description
Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.
By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?
Guest:
Peter Aldhous, science reporter at Buzzfeed News
Host
Lizzie O’Leary
Learn more about your ad choices. Visit megaphone.fm/adchoices
How the semi-legalization of marijuana has drawn a road map for legalizing psychedelics—and also provided a list of pitfalls to be avoided.
Guest: Jane C. Hu, science journalist and author of the newsletter The Microdose.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free...
Published 04/14/24
Why lately our search engines just don’t seem to deliver results.
Guest: Jason Koebler, cofounder of 404 Media and co-host of the 404 Media Podcast.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts....
Published 04/12/24